Photodynamic therapy (PDT) is a promising treat ment method, which was shown to be effective for var ious types of cancer [1] . This method is based on selec tive accumulation of photosensitizers in cancer cells, with subsequent irradiation of the tumor at one of the absorption peaks of photosensitizers [2] . The active cytotoxic principle of photosensitizers are reactive oxygen species (ROS), primarily singlet oxygen and hydroxyl radical, whose radius of action is less than 20 nm [2] . The cell nucleus is a cellular compartment, that is the most sensitive to the damaging effect of ROS, and consequently, to the photocytotoxic effect of photosensitizers [3, 4] . It was shown that free pho tosensitizers do not accumulate in the nucleus in detectable amount [2] ; therefore, to reach the maxi mum effect of PDT with the minimum dose of a pho tosensitizer (and, thus, to minimize the side effects of therapy), it seems reasonable to ensure not only selec tive accumulation of photosensitizers in tumor cells but also their targeted delivery into the cell nucleus.
To perform selective targeted delivery of locally acting anticancer drugs to the nucleus of melanoma cells, modular nanotransporters (MNTs) using natural cellular mechanisms of transport and macromolecule sorting have been developed. MNTs are recombinant polypeptides whose functional modules ensure (1) selective recognition of the target cell with its subse quent endocytosis, due to the ligand module, α mel anocyte stimulating hormone (α MSH), a ligand for internalized melanocortin receptors overexpressed on the surface of melanoma cells [4] ; (2) release from the endosome into the cytoplasm, due to the translocation domain of the diphtheria toxin (DTox); (3) transport into the nucleus, due to the optimized nuclear local ization sequence (NLS) of the SV40 large T antigen; and (4) effective attachment of the delivered drug, ensured by the carrier module, hemoglobin like pro tein (HMP) of E. coli. Earlier, it was shown for cul tured melanoma cells that the photosensitizers conju gated to MNTs were two orders of magnitude more efficient than the free photosensitizers [4] .
The main obstacle to using PDT for the treatment of pigmented melanoma is melanin, which determines its pigmentation and absorbs light, thereby hampering its penetration into deeper layers of tissue [5] . How ever, the pronounced effect of MNTs on melanoma cells in vitro [4, 6] allowed us to assume that the small amounts of light penetrating the tumor may be suffi cient for the manifestation of the effect of a photosen sitizer delivered by MNT into the nucleus, the most sensitive compartment. In this study, bacteriochlorin p, synthesized under the supervision of Professor A.F. Mironov, Lomonosov State Academy of Fine Chemical Technology, Moscow, was used as a photo sensitizer. This compound has a long wavelength absorption maximum (761 nm) shifted to the region where the melanin absorbtion is weaker and the tissue is more transparent [7] . Taking into account the fact that melanomas are highly heterogeneous in the con tent of melanin (from amelanotic to completely black), in this study we used two models of melanoma with different levels of pigmentation-weakly pig mented Cloudman S91 melanoma (clone M3) and highly pigmented melanoma B16 F1.
The modular nanotransporter DTox-HMP-NLS-αMSH was synthesized and purified as described previously [4] . To study the distribution of the MNT in the tissues of tumor bearing mice, MNT was radioactively labeled using the iodination agent N succinimidyl 3 [ a labeled product resistant to deiodination in vivo [8] .
To perform PDT, MNT was conjugated to the photo sensitizer bacteriochlorin p [4] . Since the delivered photosensitizer exerts its pho tocytotoxic effect only within the irradiated area, the distribution of the transporter between the tumor and its immediate environment is the most important for PDT. The selectivity of accumulation of the MNT in the B16 F1 tumor transplanted to C57Black/6J mice (Tables 1, 2) significantly increased with MNT doses starting from 9.7 mg/kg body weight and reached the optimal tumor to muscle ratio of specific radioactivities (13.4 ± 1.7) at a dose of 38.6 mg/kg as early as 3 h after intravenous injection. Despite the tendency to an increased accumulation of the label in the skin compared to the muscle, presumably due to the presence of melanocortin receptors on melano cytes, the optimal ratios of tumor to skin specific radioactivities (9.8 ± 1.8) at a dose of 9.7 mg/kg were 3-8 times greater than the published ratios for the free photosensitizers for the same B16 melanoma model [9] [10] [11] .
As the time elapsed after the injection increased to 15 h, the tumor to surrounding tissue specific radio activities ratio of the specific radioactivities tended to increase, although the absolute content of the label both in the tumor and in other tissues significantly decreased over time, dropping down by more than 90% over the period from 3 to 15 h. Taking this into account, for the therapy of C57Black/6J mice with transplanted melanoma B16 F1, we used several dif ferent schemes of irradiation. In the first scheme, mice were irradiated three times (3, 6 , and 9 h after the injec tion of the photosensitizer conjugated to MNT) with increasing light dose from the first to the third exposure, which ensured a high efficacy of therapy with the use of the photosensitizer conjugated to MNT (Table 3) .
Another scheme, which included a single exposure 3 h after intravenous injection of the photosensitizer conjugated to MNT, showed a similar effect of PDT with a considerable simplification of the treatment (Table 3) .
Even a more pronounced inhibition of tumor growth and increased survival rates were obtained using the model of a less pigmented Cloudman S91 melanoma (Table 3) .
To study the intracellular distribution of MNT at the time of irradiation, we performed immunofluores cent staining of tumor sections. Subsequent analysis of the sections under an LSM 510 Meta NLO confocal laser scanning microscope (Carl Zeiss, Germany) revealed the accumulation of the MNT in the nuclei of tumor cells (Table 4) .
Thus, in this study we demonstrated highly selec tive accumulation of MNT in melanoma as compared to the surrounding healthy tissue and its significant concentration in the nuclei of tumor cells in vivo, which ensured 93% melanoma growth inhibition and a significant increase in the lifespan of animals that Note: BChl-bacteriochlorin. Differences from the respective group "BChl" were significant at * p < 0.002 and ** p < 0.05 (according to the Mantel-Hansel test).
were treated with the photosensitizer conjugated to the MNT as compared to the animals treated with the free photosensitizer. 
